Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 22

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 22
---
 $   per share would increase (decrease) the net proceeds to us from the sale of the Class A Common Stock offered by us by $   million, assuming the number of                                
 shares offered by us, as set forth on the cover page of this prospectus, remains the same, after deducting estimated underwriting discounts and commissions and estimated offering expenses. Similarly, an increase (decrease) of one million shares in 
 the number of shares sold in this offering by us would increase (decrease) the net proceeds to us from this offering by $   million, assuming the initial public offering price of $   per share, which is the midpoint of the                          
 estimated public offering price range set forth on the cover page of this prospectus, remains the same.                                                                                                                                                 |

| We intend to contribute all of the net proceeds from this offering (not including the exercise of the underwriters’                                                                                                       
 option to purchase additional shares) to Legence Holdings in exchange for LGN Units. Legence Holdings intends to use such net proceeds from this offering for the repayment of outstanding borrowings under our Term Loan |

10

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83

| Credit Facility and the remaining proceeds for general corporate purposes. |

| If the underwriters exercise their option to purchase additional shares of Class A Common Stock in full, the additional net proceeds to us will be approximately $   million (based on an assumed initial                                           
 offering price of $   per share, which is the midpoint of the price range set forth on the cover page of this prospectus), after deducting underwriting discounts and commissions. We intend to contribute the net proceeds received from the       
 sale of any additional shares by us to Legence Holdings in exchange for additional LGN Units being issued to Legence Sub, and Legence Holdings will use such net proceeds to purchase LGN Units, together with an equal number of shares of Class B 
 Common Stock, from Aggregator I at a purchase price per LGN Unit and share of Class B Common Stock equal to the public offering price per share of Class A Common Stock in this offering, net of underwriting discounts and commissions.            |

| We will not receive any proceeds from the sale of additional shares in this offering by the selling stockholder. |

| The section titled “Use of Proceeds” contains additional information regarding our intended use of proceeds from